CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Jae Hyun Bae, Sunhee Kim, Eun-Gee Park, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
Endocrinol Metab. 2019;34(1):80-92.   Published online March 21, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.1.80

Excel Download

Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Jae Hyun Bae, Sunhee Kim, Eun-Gee Park, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
Endocrinology and Metabolism. 2019;34(1):80   Crossref logo
Link1 Link2 Link3
Comparative Renal Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Individual Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Jae Hyun Bae, Eun-Gee Park, Sunhee Kim, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
Endocrinology and Metabolism. 2021;36(2):388-400   Crossref logo
Link1 Link2 Link3
Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis
K. Gooßen, S. Gräber
Diabetes, Obesity and Metabolism. 2012;14(12):1061-1072   Crossref logo
Link1 Link2
Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis
Dan Liu, Biao Jin, Wei Chen, Peng Yun
BMC Pharmacology and Toxicology. 2019;20(1):   Crossref logo
Link1 Link2 Link3
Effect of Dipeptidyl Peptidase-4 Inhibitors on Hemoglobin a1c In Patients with Type 2 Diabetes Mellitus and Renal Impairment: a Systematic Review and Meta-analysis
D. Singh-Franco, C. Harrington, E. Tellez-Corrales
Value in Health. 2015;18(3):A55   Crossref logo
Link1 Link2
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus Patients with Moderate to Severe Renal Impairment: A Systematic Review and Meta-Analysis
Dongsheng Cheng, Yang Fei, Yumei Liu, Junhui Li, Yuqiang Chen, Xiaoxia Wang, Niansong Wang
PLoS ONE. 2014;9(10):e111543   Crossref logo
Link1
New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors
Chan-Hee Jung
Endocrinology and Metabolism. 2021;36(2):339-341   Crossref logo
Link1 Link2 Link3
The Effect of Dipeptidyl Peptidase-4 Inhibitors on Carotid Intima-media Thickness in Patients With Type 2 Diabetes Mellitus: a Meta-analysis
Hua-song Xia, Yue Liu, Yang Fu, Meng Li, Yan-qing Wu
. 2020;   Crossref logo
Link1 Link2
Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis
F. Barkas, M. Elisaf, V. Tsimihodimos, H. Milionis
Diabetes & Metabolism. 2017;43(1):1-8   Crossref logo
Link1 Link2
Dipeptidyl peptidase-4 inhibitors and risk of arthralgia: A systematic review and meta-analysis
P. Men, N. He, C. Song, S. Zhai
Diabetes & Metabolism. 2017;43(6):493-500   Crossref logo
Link1 Link2